Christopher Strouse, MD, clinical assistant professor and hematologist within the Division of Hematology, Oncology, and Blood & Marrow Transplantation, now leads the multidisciplinary oncology group (MOG) for myeloma at UI’s Holden Comprehensive Cancer Center (HCCC). MOGs, as detailed here, are defined teams within the HCCC, each one organized around a specific type of cancer. There […]
The following is reprinted from the February 6 issue of the UI Holden Comprehensive Cancer Center’s Holden Highlights newsletter. See other features from this series. Graduate Student Spotlight: Shakoora Sabree, Medical Scientist Training Program As a native of Stone Mountain, Georgia, Shakoora Sabree’s undergraduate education took her to Agnes Scott College in Decatur, GA, where […]
The fifth and final session in a new Integrated Behavioral Oncology curriculum designed by Arwa Aburizik, MD, MS, will occur on Tuesday, February 8, from 8 to 9 am. Titled “Ethical Questions in Oncology,” this session will be led by Janeta Tansey, MD, PhD, former clinical faculty member in the UI Department of Psychiatry and […]
The following is a guest post from the leadership at the University of Iowa’s Holden Comprehensive Cancer Center. Saima Sharif, MD, MS, has been appointed the Medical Director for 4JPP (Team A). This unit located on the main campus of University of Iowa Hospitals & Clinics treats primarily hematology/oncology inpatients. Dr. Sharif is an associate […]
Opening any clinical trial requires the satisfaction of many regulatory requirements for very good reasons. Scores of people review applications, confer in committees, weigh risks and benefits, all to make sure that the investigator has patient safety as their guide. This process is important, but it can also be lengthy and overlong delays can doom a trial before it can even […]
Karima Ait-Aissa, PhD, associate in Cardiovascular Medicine, received a $30,000 American Cancer Society Institutional Research Grant from the University of Iowa Holden Comprehensive Cancer Center. Her project, titled “New Approaches to Mitigate Radiation Therapy-Induced Cognitive Impairment,” aims to take a step toward preventing morbidity as a result of radiation therapy. With this seed grant, Ait-Aissa […]
Muhammad Furqan, MD, associate professor in Hematology, Oncology, and Blood & Marrow Transplantation and leader of the Thoracic Multidisciplinary Oncology Group at the Holden Comprehensive Cancer Center (HCCC), has received a 2020 Cancer Clinical Investigator Team Leadership Award (CCITLA) from the National Cancer Institute. This two-year, $119,982 award recognizes Furqan’s passion, advocacy, and hard work […]
Genitourinary (GU) cancers, including prostate cancer, are the most common among men, and Rohan Garje, MBBS, clinical assistant professor in the Division of Hematology, Oncology, and Marrow Transplantation, has made them his singular focus. With two publications in the last month and multiple projects underway, the former fellow and recent addition to the faculty is […]
Sneha Phadke, DO, assistant clinical professor in Hematology, Oncology and Blood & Marrow Transplantation and a breast medical oncologist at the Holden Comprehensive Cancer Center (HCCC), is investigating the cognitive deficits that occur following chemotherapy, which has often been called “chemo brain.” Last month, Phadke and associate research scientist Kanchna Ramchandran, MS, PhD, were awarded […]
Cholangiocarcinoma (CCA) is a cancer that arises from bile ducts/channels draining bile in the liver and often includes the gallbladder cancers. CCA is the second most common form of cancerous liver lesions. In 2017, Linda Kilcrease came to Pashtoon Kasi, MD, MS (then at Mayo Clinic), with metastatic cancer, but it was not amenable or […]